Toxicokinetic behaviors and modes of perfluorooctane sulfonate (PFOS) and perfluorooctane acid (PFOA) on tilapia (Oreochromis niloticus)

African Journal of Biotechnology

Volumn 10, Issue 60, 2011, Pages 12943-12950

  Han, Zhao Xiang ^a   Zhang, Meng ^a   Lv, Chun Xia ^b  

^a HUAIHAI INSTITUTE OF TECHNOLOGY   (China)

^b Jiaonan Agricultural Bureau   (China)

Author keywords

Behaviors; Perfluorooctane acid (PFOA); Perfluorooctane sulfonate (PFOS); Tilapia (Oreochromis niloticus); Toxicokinetic

Indexed keywords

PERFLUOROOCTANE; PERFLUOROOCTANESULFONIC ACID; TESTOSTERONE 17BETA DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CLEARANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISTRIBUTION VOLUME; ENZYME INHIBITION; FEMALE; HALF LIFE TIME; LIMIT OF QUANTITATION; MALE; NONHUMAN; OREOCHROMIS NILOTICUS; PERIPHERAL LYMPHOCYTE; SEX DIFFERENCE; TOXICOKINETICS;

OREOCHROMIS NILOTICUS; TILAPIA;

EID: 80054029956     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: 10.5897/ajb11.1767     Document Type: Article

References (23)

1. Chu Y, Zhao B, Huang Y (2009). Inhibition of 3β- and 17β-hydroxysteroid dehydrogenase activities in rat Leydig cells by PFOA. Asian J. Androl. 142: p. 11.
2. Falandysz J, Taniyasu S, Gulkowska A, Yamashita N, Schulte-Oehlmann U (2006). Is fish a major source of fluorinated surfactants and repellents in human living on the Baltic coast? Environ. Sci. Technol. 40: 748-751.
3. Giesy JP, Kannan K (2002). Perfluorochemical surfactants in the environment. Environ. Sci. Technol. 36: 147-152.
4. Guruge KS, Manage MP, Miyazaki S, Yamanaka N, Taniyasu S, Hanari N, Yamashita N (2005). Species-specific accumulation of perfluorinated compounds in farm and pet animals from Japan. Organohalogen. Compd. 67: 823-826.
5. Hoff PT, Van Dongen W, Esmans EL, Blust R, De Coen WM (2003a). Evaluation of the toxicological effects of perfluorooctane sulfonic acid in the common carp (Cyprinus carpio). Aquat. Toxicol. 62: 349-359.
6. Hu GX, Zhou HY, Zh XW (2009). The (+)- and (-)-gossypols potently inhibit both 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase3 in human and rat testes. J. Steroid Biochem. Mol. Biol. 115(12): 14-19.
7. Huang HH, Hua ChJ (2010). Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS). Aquat. Toxicol. 98(2): 139-147.
8. Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, Mohd MA, Olivero J, Wouwe NV, Yang JH, Aldous KM (2004). Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 38: 4489-4495.
9. Kissa E (2001). Fluorinated Surfactants and Repellents, second ed. Marcel Dekker, New York.
10. Kudo N, Katakura M, Sato Y, Kawashima Y (2002). Sex hormoneregulated renal transport of perfluorooctanoic acid. Chem. Biol. Interact. 139: 301-316.
11. Lau C, Butenhoff JL, Rogers JM (2004). The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 198: 231-241.
12. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse.II. Postnatal evaluation. Toxicol. Sci. 74: 382-392.
13. Luebker DJ, Case MT, York RG, Moore JA, Hansen KJ, Butenhoff JL (2005). Two-generation reproduction and crossfoster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology, 215: 126-148.
14. Michael E Baker (2004). Evolutionary analysis of 11β-hydroxysteroid dehydrogenase-type 1,-type 2, -type 3 and 17β-hydroxysteroid dehydrogenase-type 2 in fish. FEBS Lett. 574: 167-170.
15. Olsen GW, Huang HY, Helzlsouer KJ, Hansen KJ, Butenhoff JL, Mandel JH (2005). Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ. Health Perspect. 113: 539-545.
16. Seacat AM, Thomford PJ, Hansen KJ, Clemen LA, Eldridge SR, Elcombe CR, Butenhoff JL (2003). Subchronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology,183: 117-131.
17. Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff JL (2002). Subchronic toxicity studies on perfluorooctane- sulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 68: 249-264.
18. Tang J, Yang XL (2006). Pharmacokinetics and the active metabolite of enrofloxacin in Chinese mitten-handed crab (Eriocheir sinensis). Aquaculture, 260: 69-76.
19. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I. Maternal and prenatal evaluations. Toxicol. Sci. 74: 369-381.
20. USEPA OPPTS (2002). Risk Assessment Division. Revised draft hazard assessment of perfluorooctanoic acid and its salts. AR226-1136.Washington, DC.
21. Vanden Heuval J, Kuslikis B, Van Rafelghem MJ, Peterson R (1991) Tissue distribution, metabolism, and elimination of perfluoroactanoic acid in male and female rats. J Biochem. Toxicol. 6(2): 83-92.
22. Ylinen M, Kojo A, Hanhijdrvi H, Peura P (1990). Disposition of perfluorooctanoic acid in the rat after single and subchronic administration. Bull. Environ. Contam. Toxicol. 44: 46-53.
23. Zhao BH, Hu GX, Hua GX (2010). Inhibition of human and rat 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 activities by perfluoroalkylated substances. Chem. Biol. Interac. 188: 38-43.